PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Interim Guidelines for Pregnant Women During a Zika Virus Outbreak--United States, 2016.

Abstract CDC has developed interim guidelines for health care providers in the United States caring for pregnant women during a Zika virus outbreak. These guidelines include recommendations for pregnant women considering travel to an area with Zika virus transmission and recommendations for screening, testing, and management of pregnant returning travelers. Updates on areas with ongoing Zika virus transmission are available online (http://wwwnc.cdc.gov/travel/notices/). Health care providers should ask all pregnant women about recent travel. Pregnant women with a history of travel to an area with Zika virus transmission and who report two or more symptoms consistent with Zika virus disease (acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis) during or within 2 weeks of travel, or who have ultrasound findings of fetal microcephaly or intracranial calcifications, should be tested for Zika virus infection in consultation with their state or local health department. Testing is not indicated for women without a travel history to an area with Zika virus transmission. In pregnant women with laboratory evidence of Zika virus infection, serial ultrasound examination should be considered to monitor fetal growth and anatomy and referral to a maternal-fetal medicine or infectious disease specialist with expertise in pregnancy management is recommended. There is no specific antiviral treatment for Zika virus; supportive care is recommended.
PMID
Related Publications

Travel-Associated Zika Virus Disease Cases Among U.S. Residents--United States, January 2015-February 2016.

Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection--United States, February 2016.

Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016.

Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016.

Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016.

Authors

Mayor MeshTerms

Disease Outbreaks

Practice Guidelines as Topic

Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start
%A Petersen, Emily E.; Staples, J. Erin; Meaney-Delman, Dana; Fischer, Marc; Ellington, Sascha R.; Callaghan, William M.; Jamieson, Denise J.
%T Interim Guidelines for Pregnant Women During a Zika Virus Outbreak--United States, 2016.
%J MMWR. Morbidity and mortality weekly report, vol. 65, no. 2, pp. 30-33
%D 01/2016
%V 65
%N 2
%M eng
%B CDC has developed interim guidelines for health care providers in the United States caring for pregnant women during a Zika virus outbreak. These guidelines include recommendations for pregnant women considering travel to an area with Zika virus transmission and recommendations for screening, testing, and management of pregnant returning travelers. Updates on areas with ongoing Zika virus transmission are available online (http://wwwnc.cdc.gov/travel/notices/). Health care providers should ask all pregnant women about recent travel. Pregnant women with a history of travel to an area with Zika virus transmission and who report two or more symptoms consistent with Zika virus disease (acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis) during or within 2 weeks of travel, or who have ultrasound findings of fetal microcephaly or intracranial calcifications, should be tested for Zika virus infection in consultation with their state or local health department. Testing is not indicated for women without a travel history to an area with Zika virus transmission. In pregnant women with laboratory evidence of Zika virus infection, serial ultrasound examination should be considered to monitor fetal growth and anatomy and referral to a maternal-fetal medicine or infectious disease specialist with expertise in pregnancy management is recommended. There is no specific antiviral treatment for Zika virus; supportive care is recommended.
%K Centers for Disease Control and Prevention (U.S.), Disease Outbreaks, Female, Humans, Mass Screening, Practice Guidelines as Topic, Pregnancy, Pregnancy Complications, Infectious, Travel, United States, Zika Virus Infection
%P 30
%L 33
%Y 10.15585/mmwr.mm6502e1
%W PHY
%G AUTHOR
%R 2016.......65...30P

@Article{Petersen2016,
author="Petersen, Emily E.
and Staples, J. Erin
and Meaney-Delman, Dana
and Fischer, Marc
and Ellington, Sascha R.
and Callaghan, William M.
and Jamieson, Denise J.",
title="Interim Guidelines for Pregnant Women During a Zika Virus Outbreak--United States, 2016.",
journal="MMWR. Morbidity and mortality weekly report",
year="2016",
month="Jan",
day="22",
volume="65",
number="2",
pages="30--33",
keywords="Centers for Disease Control and Prevention (U.S.)",
keywords="Disease Outbreaks",
keywords="Female",
keywords="Humans",
keywords="Mass Screening",
keywords="Practice Guidelines as Topic",
keywords="Pregnancy",
keywords="Pregnancy Complications, Infectious",
keywords="Travel",
keywords="United States",
keywords="Zika Virus Infection",
abstract="CDC has developed interim guidelines for health care providers in the United States caring for pregnant women during a Zika virus outbreak. These guidelines include recommendations for pregnant women considering travel to an area with Zika virus transmission and recommendations for screening, testing, and management of pregnant returning travelers. Updates on areas with ongoing Zika virus transmission are available online (http://wwwnc.cdc.gov/travel/notices/). Health care providers should ask all pregnant women about recent travel. Pregnant women with a history of travel to an area with Zika virus transmission and who report two or more symptoms consistent with Zika virus disease (acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis) during or within 2 weeks of travel, or who have ultrasound findings of fetal microcephaly or intracranial calcifications, should be tested for Zika virus infection in consultation with their state or local health department. Testing is not indicated for women without a travel history to an area with Zika virus transmission. In pregnant women with laboratory evidence of Zika virus infection, serial ultrasound examination should be considered to monitor fetal growth and anatomy and referral to a maternal-fetal medicine or infectious disease specialist with expertise in pregnancy management is recommended. There is no specific antiviral treatment for Zika virus; supportive care is recommended.",
issn="1545-861X",
doi="10.15585/mmwr.mm6502e1",
url="http://www.ncbi.nlm.nih.gov/pubmed/26796813",
language="eng"
}

%0 Journal Article
%T Interim Guidelines for Pregnant Women During a Zika Virus Outbreak--United States, 2016.
%A Petersen, Emily E.
%A Staples, J. Erin
%A Meaney-Delman, Dana
%A Fischer, Marc
%A Ellington, Sascha R.
%A Callaghan, William M.
%A Jamieson, Denise J.
%J MMWR. Morbidity and mortality weekly report
%D 2016
%8 Jan 22
%V 65
%N 2
%@ 1545-861X
%G eng
%F Petersen2016
%X CDC has developed interim guidelines for health care providers in the United States caring for pregnant women during a Zika virus outbreak. These guidelines include recommendations for pregnant women considering travel to an area with Zika virus transmission and recommendations for screening, testing, and management of pregnant returning travelers. Updates on areas with ongoing Zika virus transmission are available online (http://wwwnc.cdc.gov/travel/notices/). Health care providers should ask all pregnant women about recent travel. Pregnant women with a history of travel to an area with Zika virus transmission and who report two or more symptoms consistent with Zika virus disease (acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis) during or within 2 weeks of travel, or who have ultrasound findings of fetal microcephaly or intracranial calcifications, should be tested for Zika virus infection in consultation with their state or local health department. Testing is not indicated for women without a travel history to an area with Zika virus transmission. In pregnant women with laboratory evidence of Zika virus infection, serial ultrasound examination should be considered to monitor fetal growth and anatomy and referral to a maternal-fetal medicine or infectious disease specialist with expertise in pregnancy management is recommended. There is no specific antiviral treatment for Zika virus; supportive care is recommended.
%K Centers for Disease Control and Prevention (U.S.)
%K Disease Outbreaks
%K Female
%K Humans
%K Mass Screening
%K Practice Guidelines as Topic
%K Pregnancy
%K Pregnancy Complications, Infectious
%K Travel
%K United States
%K Zika Virus Infection
%U http://dx.doi.org/10.15585/mmwr.mm6502e1
%U http://www.ncbi.nlm.nih.gov/pubmed/26796813
%P 30-33

PT Journal
AU Petersen, EE
   Staples, JE
   Meaney-Delman, D
   Fischer, M
   Ellington, SR
   Callaghan, WM
   Jamieson, DJ
TI Interim Guidelines for Pregnant Women During a Zika Virus Outbreak--United States, 2016.
SO MMWR. Morbidity and mortality weekly report
JI MMWR Morb. Mortal. Wkly. Rep.
PD Jan
PY 2016
BP 30
EP 33
VL 65
IS 2
DI 10.15585/mmwr.mm6502e1
LA eng
DE Centers for Disease Control and Prevention (U.S.); Disease Outbreaks; Female; Humans; Mass Screening; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Travel; United States; Zika Virus Infection
AB CDC has developed interim guidelines for health care providers in the United States caring for pregnant women during a Zika virus outbreak. These guidelines include recommendations for pregnant women considering travel to an area with Zika virus transmission and recommendations for screening, testing, and management of pregnant returning travelers. Updates on areas with ongoing Zika virus transmission are available online (http://wwwnc.cdc.gov/travel/notices/). Health care providers should ask all pregnant women about recent travel. Pregnant women with a history of travel to an area with Zika virus transmission and who report two or more symptoms consistent with Zika virus disease (acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis) during or within 2 weeks of travel, or who have ultrasound findings of fetal microcephaly or intracranial calcifications, should be tested for Zika virus infection in consultation with their state or local health department. Testing is not indicated for women without a travel history to an area with Zika virus transmission. In pregnant women with laboratory evidence of Zika virus infection, serial ultrasound examination should be considered to monitor fetal growth and anatomy and referral to a maternal-fetal medicine or infectious disease specialist with expertise in pregnancy management is recommended. There is no specific antiviral treatment for Zika virus; supportive care is recommended.
ER

PMID- 26796813
OWN - NLM
STAT- MEDLINE
DA  - 20160122
DCOM- 20160523
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 65
IP  - 2
DP  - 2016 Jan 22
TI  - Interim Guidelines for Pregnant Women During a Zika Virus Outbreak--United
      States, 2016.
PG  - 30-3
LID - 10.15585/mmwr.mm6502e1 [doi]
AB  - CDC has developed interim guidelines for health care providers in the United
      States caring for pregnant women during a Zika virus outbreak. These guidelines
      include recommendations for pregnant women considering travel to an area with
      Zika virus transmission and recommendations for screening, testing, and
      management of pregnant returning travelers. Updates on areas with ongoing Zika
      virus transmission are available online (http://wwwnc.cdc.gov/travel/notices/).
      Health care providers should ask all pregnant women about recent travel. Pregnant
      women with a history of travel to an area with Zika virus transmission and who
      report two or more symptoms consistent with Zika virus disease (acute onset of
      fever, maculopapular rash, arthralgia, or conjunctivitis) during or within 2
      weeks of travel, or who have ultrasound findings of fetal microcephaly or
      intracranial calcifications, should be tested for Zika virus infection in
      consultation with their state or local health department. Testing is not
      indicated for women without a travel history to an area with Zika virus
      transmission. In pregnant women with laboratory evidence of Zika virus infection,
      serial ultrasound examination should be considered to monitor fetal growth and
      anatomy and referral to a maternal-fetal medicine or infectious disease
      specialist with expertise in pregnancy management is recommended. There is no
      specific antiviral treatment for Zika virus; supportive care is recommended.
FAU - Petersen, Emily E
AU  - Petersen EE
FAU - Staples, J Erin
AU  - Staples JE
FAU - Meaney-Delman, Dana
AU  - Meaney-Delman D
FAU - Fischer, Marc
AU  - Fischer M
FAU - Ellington, Sascha R
AU  - Ellington SR
FAU - Callaghan, William M
AU  - Callaghan WM
FAU - Jamieson, Denise J
AU  - Jamieson DJ
LA  - eng
PT  - Journal Article
DEP - 20160122
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Centers for Disease Control and Prevention (U.S.)
MH  - *Disease Outbreaks
MH  - Female
MH  - Humans
MH  - Mass Screening
MH  - *Practice Guidelines as Topic
MH  - Pregnancy
MH  - Pregnancy Complications, Infectious/diagnosis/therapy
MH  - Travel
MH  - United States/epidemiology
MH  - Zika Virus Infection/diagnosis/*epidemiology/therapy
EDAT- 2016/01/23 06:00
MHDA- 2016/05/24 06:00
CRDT- 2016/01/23 06:00
AID - 10.15585/mmwr.mm6502e1 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2016 Jan 22;65(2):30-3. doi: 10.15585/mmwr.mm6502e1.
TY  - JOUR
AU  - Petersen, Emily E.
AU  - Staples, J. Erin
AU  - Meaney-Delman, Dana
AU  - Fischer, Marc
AU  - Ellington, Sascha R.
AU  - Callaghan, William M.
AU  - Jamieson, Denise J.
PY  - 2016/Jan/22
TI  - Interim Guidelines for Pregnant Women During a Zika Virus Outbreak--United States, 2016.
T2  - MMWR Morb. Mortal. Wkly. Rep.
JO  - MMWR. Morbidity and mortality weekly report
SP  - 30
EP  - 33
VL  - 65
IS  - 2
KW  - Centers for Disease Control and Prevention (U.S.)
KW  - Disease Outbreaks
KW  - Female
KW  - Humans
KW  - Mass Screening
KW  - Practice Guidelines as Topic
KW  - Pregnancy
KW  - Pregnancy Complications, Infectious
KW  - Travel
KW  - United States
KW  - Zika Virus Infection
N2  - CDC has developed interim guidelines for health care providers in the United States caring for pregnant women during a Zika virus outbreak. These guidelines include recommendations for pregnant women considering travel to an area with Zika virus transmission and recommendations for screening, testing, and management of pregnant returning travelers. Updates on areas with ongoing Zika virus transmission are available online (http://wwwnc.cdc.gov/travel/notices/). Health care providers should ask all pregnant women about recent travel. Pregnant women with a history of travel to an area with Zika virus transmission and who report two or more symptoms consistent with Zika virus disease (acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis) during or within 2 weeks of travel, or who have ultrasound findings of fetal microcephaly or intracranial calcifications, should be tested for Zika virus infection in consultation with their state or local health department. Testing is not indicated for women without a travel history to an area with Zika virus transmission. In pregnant women with laboratory evidence of Zika virus infection, serial ultrasound examination should be considered to monitor fetal growth and anatomy and referral to a maternal-fetal medicine or infectious disease specialist with expertise in pregnancy management is recommended. There is no specific antiviral treatment for Zika virus; supportive care is recommended.
SN  - 1545-861X
UR  - http://dx.doi.org/10.15585/mmwr.mm6502e1
UR  - http://www.ncbi.nlm.nih.gov/pubmed/26796813
ID  - Petersen2016
ER  - 
<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
<b:Source>
<b:Tag>Petersen2016</b:Tag>
<b:SourceType>ArticleInAPeriodical</b:SourceType>
<b:Year>2016</b:Year>
<b:Month>Jan</b:Month>
<b:Day>22</b:Day>
<b:PeriodicalName>MMWR. Morbidity and mortality weekly report</b:PeriodicalName>
<b:Volume>65</b:Volume>
<b:Issue>2</b:Issue>
<b:Pages>30-33</b:Pages>
<b:Author>
<b:Author><b:NameList>
<b:Person><b:Last>Petersen</b:Last><b:First>Emily</b:First><b:Middle>E</b:Middle></b:Person>
<b:Person><b:Last>Staples</b:Last><b:First>J</b:First><b:Middle>Erin</b:Middle></b:Person>
<b:Person><b:Last>Meaney-Delman</b:Last><b:First>Dana</b:First></b:Person>
<b:Person><b:Last>Fischer</b:Last><b:First>Marc</b:First></b:Person>
<b:Person><b:Last>Ellington</b:Last><b:First>Sascha</b:First><b:Middle>R</b:Middle></b:Person>
<b:Person><b:Last>Callaghan</b:Last><b:First>William</b:First><b:Middle>M</b:Middle></b:Person>
<b:Person><b:Last>Jamieson</b:Last><b:First>Denise</b:First><b:Middle>J</b:Middle></b:Person>
</b:NameList></b:Author>
</b:Author>
<b:Title>Interim Guidelines for Pregnant Women During a Zika Virus Outbreak--United States, 2016.</b:Title>
 <b:ShortTitle>MMWR Morb. Mortal. Wkly. Rep.</b:ShortTitle>
<b:Comments>CDC has developed interim guidelines for health care providers in the United States caring for pregnant women during a Zika virus outbreak. These guidelines include recommendations for pregnant women considering travel to an area with Zika virus transmission and recommendations for screening, testing, and management of pregnant returning travelers. Updates on areas with ongoing Zika virus transmission are available online (http://wwwnc.cdc.gov/travel/notices/). Health care providers should ask all pregnant women about recent travel. Pregnant women with a history of travel to an area with Zika virus transmission and who report two or more symptoms consistent with Zika virus disease (acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis) during or within 2 weeks of travel, or who have ultrasound findings of fetal microcephaly or intracranial calcifications, should be tested for Zika virus infection in consultation with their state or local health department. Testing is not indicated for women without a travel history to an area with Zika virus transmission. In pregnant women with laboratory evidence of Zika virus infection, serial ultrasound examination should be considered to monitor fetal growth and anatomy and referral to a maternal-fetal medicine or infectious disease specialist with expertise in pregnancy management is recommended. There is no specific antiviral treatment for Zika virus; supportive care is recommended.</b:Comments>
</b:Source>
</b:Sources>